PolyPeptide Group
Torrance, CA · Strasbourg, FR · Malmo, SE
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
66.1
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (7)
○ EMA GMP
○ MHRA GMP
Quick Facts: PolyPeptide Group
- Signal Score
- 66.1/100 (as of 2026-09-07)
- Quality Compliance
- 74.2/100
- Headquarters
- Torrance, CA · Strasbourg, FR · Malmo, SE
- Modalities
- Oligonucleotide
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About PolyPeptide Group
Pure-play CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
74.2
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-05-15)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesOligonucleotide
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
Recent Press7 articles
PolyPeptide Group FDA Inspection History
2025-05
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-05-15 |
PolyPeptide Laboratories San Diego LLC
San Diego, California
Facility-linked
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 07, 2026
Attribution not established
(2)
These records are excluded from this company’s established evidence
because their attribution is unresolved. This describes an evidence-linking
limitation, not an assessment of the underlying regulatory findings.
| Source | Establishment named by the regulator | Location | Identifier |
|---|---|---|---|
| FDA inspection | Winder Laboratories, LLC | Winder, Georgia | FDA/FEI=3008694072 |
| FDA inspection | Winder Laboratories, LLC | Winder, Georgia | FDA/FEI=3008694072 |
Source records retained verbatim · attribution not established
Recent News 7 articles
PolyPeptide Group AG takes note of market rumors and speculation - TradingView — Track All Markets
PolyPeptide Group AG takes note of market rumors and speculation TradingView
PolyPeptide explores options as EQT, Advent, and KKR show interest - pe-insights.com
PolyPeptide explores options as EQT, Advent, and KKR show interest pe-insights.com
PolyPeptide announces results of the annual General Meeting 2026 - TradingView
PolyPeptide announces results of the annual General Meeting 2026 TradingView
PolyPeptide announces results of the annual General Meeting 2026 - AD HOC NEWS
PolyPeptide announces results of the annual General Meeting 2026 AD HOC NEWS
PolyPeptide publishes invitation to the annual General Meeting 2026 - TradingView
PolyPeptide publishes invitation to the annual General Meeting 2026 TradingView
PolyPeptide Group / CH1110760852 - AD HOC NEWS
PolyPeptide Group / CH1110760852 AD HOC NEWS
PolyPeptide delivers strong revenue growth and marked improvement in profitability - TradingView
PolyPeptide delivers strong revenue growth and marked improvement in profitability TradingView
Frequently Asked Questions About PolyPeptide Group
How many FDA inspections does PolyPeptide Group have on record?
CDMO Signal tracks 1 FDA inspection for PolyPeptide Group, sourced from the FDA inspection database. See the full inspection history above.
Has PolyPeptide Group received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for PolyPeptide Group.
What is PolyPeptide Group's CDMO Signal Score?
PolyPeptide Group has a Signal Score of 66/100, based on quality, operations, financial stability, and capacity data.
Evaluating PolyPeptide Group for a manufacturing program?
Use the free AI matchmaker to compare PolyPeptide Group against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 81.1
mRNA, Oligonucleotide, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.4
mRNA, Oligonucleotide, Biologics
Agilent Technologies (Oligo GMP)
Santa Clara, CA
Signal Score: 74.2
Oligonucleotide
TriLink BioTechnologies
San Diego, CA
Signal Score: 71.0
mRNA, Oligonucleotide